We are monitoring the impact of COVID-19 & Recession alarm on MEA Competent Cells Market Get in touch with us for detailed analysis Know More
Share on

Middle East & Africa Competent Cells Market Research Report - Segmented By Type, By Application, By End User & By Country (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA) - Industry Analysis, Size, Share, Growth, Trends, & Forecasts (2022 to 2027)

Published: January, 2022
ID: 3356
Pages: 137

MEA Competent Cells Market Size & Growth (2022 to 2027):

As per the research report, the size of the Middle East and Africa Competent Cells Market is valued at USD 0.17 billion in 2022 and estimated to grow at a CAGR of 6.9%, to reach USD 0.24 billion by 2027 during the forecast period 2022 to 2027.

The Middle East and Africa Competent Cells market is developing at an exceptionally quick pace.

E. coli cells are more likely to incorporate exterior DNA if their cell walls are changed so that DNA can badge through more easily. In genetics and molecular biology, competence is the ability of a cell to take up extracellular (isolated) DNA from its surroundings in the procedure called transformation. Cells are made competent by a technique that uses calcium chloride and high-temperature shock.

Expansions in molecular cloning study due to the arrival of new technologies and the increasing commercial demand for molecular cloned products and recombinant proteins are some of the key factors driving the growth of this market. However, growing market consolidation creating strong entry barriers and high cost of competent cell kits are curbing the growth of this market.

This research report segmented and sub-segmented into the following categories:

  • By Type: Chemically, Electrocompetent
  • By Application: Subcloning, Phage Display Library Production, Unstable DNA Cloning, High-Throughput Cloning, Mutagenesis
  • By End User: Pharmaceutical Companies, Academia 
  • By Country:  KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA

Cloning is estimated to command the major share of this market in 2017. Increasing study on cloning, driven by government funding is among the major reasons driving market growth in this segment. In 2016, the academic research institutes segment is likely to have for the largest share of the market.

The Middle East and Africa have an untapped market and key players are slowly expanding to this region which is the main reason for the growth of the market in this region.

The leading companies leading in the MEA Competent Cells Market profiled in the report are BioDynamics Laboratory, Inc. (Japan), GCC Biotech (India), SMOBIO Technology (Taiwan),  Thermo Fisher Scientific, Inc. (U.S), QIAGEN N.V. (Germany), OriGene Technologies (U.S.), Merck KGaA (Germany), Promega Corporation (U.S.),  Bioline (U.K.), Zymo Research (U.S.),are the leaders in the Middle East and Africa Competent Cells market.

1.Introduction          

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods  

                1.4 General Study Assumptions                

2. Research Methodology                   

                2.1 Introduction       

                2.2 Research Phases                      

        2.2.1 Secondary Research           

        2.2.2 Primary Research 

        2.2.3 Econometric Modelling      

        2.2.4 Expert Validation  

                2.3 Analysis Design 

                2.4 Study Timeline  

3. Overview               

                3.1 Executive Summary                

                3.2 Key Inferences 

                3.3 Epidemology      

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)            

                4.1 Market Drivers  

                4.2 Market Restraints                    

                4.3 Key Challenges 

                4.4 Current Opportunities in the Market      

5. Market Segmentation                      

                5.1 Type      

        5.1.1 Chemically               

        5.1.2 Electrocompetent

        5.1.3  Y-o-Y Growth Analysis, By Type    

        5.1.4  Market Attractiveness Analysis, By Type  

        5.1.5  Market Share Analysis, ByType     

                5.2 Application                 

        5.2.1 Cloning     

                        5.2.1.1  Subcloning & Routine Cloning

                        5.2.1.2 Phage Display Library Construction

                        5.2.1.3 Toxic/Unstable Dna Cloning

                        5.2.1.4 High-Throughput Cloning

        5.2.2 Protein Expression              

        5.2.3 Other Applications               

                        5.2.3.1 Mutagenesis

                        5.2.3.2 Large Plasmid Transformation

                        5.2.3.4 Single-Stranded Dna Production

                        5.2.3.5 Lentiviral Vector Production

        5.2.7 Y-o-Y Growth Analysis, By Application         

        5.2.8  Market Attractiveness Analysis, By Application      

        5.2.9  Market Share Analysis, By Application       

                5.3 End User                      

        5.3.1 Pharmaceutical Companies              

        5.3.2 Academia

        5.3.3 Y-o-Y Growth Analysis, By EndUser              

        5.3.4  Market Attractiveness Analysis, By EndUser           

        5.3.5  Market Share Analysis, By EndUser             

6. Geographical Analysis                      

                6.1 Introduction       

        6.1.1 Regional Trends    

        6.1.2 Impact Analysis     

        6.1.3 Y-o-Y Growth Analysis        

                        6.1.3.1 By Geographical Area

                        6.1.3.2 By Type

                        6.1.3.3 By Application

                        6.1.3.4 By EndUser

        6.1.4  Market Attractiveness Analysis     

                        6.1.4.1 By Geographical Area

                        6.1.4.2 By Type

                        6.1.4.3 By Application

                        6.1.4.4 By EndUser

        6.1.5  Market Share Analysis      

                        6.1.5.1 By Geographical Area

                        6.1.5.2 By Type

                        6.1.5.3 By Application

                        6.1.5.4 By EndUser

                6.2 Middle-East        

                6.3 Africa    

7.Strategic Analysis                

                7.1 PESTLE analysis 

        7.1.1 Political     

        7.1.2 Economic 

        7.1.3 Social         

        7.1.4 Technological         

        7.1.5 Legal          

        7.1.6 Environmental       

                7.2 Porter’s Five analysis      

        7.2.1 Bargaining Power of Suppliers        

        7.2.2 Bargaining Power of Consumers    

        7.2.3 Threat of New Entrants     

        7.2.4 Threat of Substitute Products and Services              

        7.2.5 Competitive Rivalry within the Industry     

8.Market Leaders' Analysis                 

                8.1 BioDynamics Laboratory, Inc. (Japan)      

        8.1.1 Overview 

        8.1.2 Product Analysis   

        8.1.3 Financial analysis  

        8.1.4 Recent Developments       

        8.1.5 SWOT analysis       

        8.1.6 Analyst View          

                8.2 GCC Biotech (India)                 

                8.3 SMOBIO Technology (Taiwan)    

                8.4 Thermo Fisher Scientific, Inc. (U.S)                   

                8.5 QIAGEN N.V. (Germany)                      

                8.6 OriGene Technologies (U.S.)      

                8.7 Merck KGaA (Germany)                       

                8.8 Promega Corporation (U.S.)                

                8.9 Bioline (U.K.)     

                8.10 Zymo Research (U.S.)  

9.Competitive Landscape                    

                9.1 Market share analysis    

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures 

                9.4 New Product Launches 

10.Market Outlook and Investment Opportunities                  

Appendix                   

                a) List of Tables                

                b) List of Figures      

  1. Middle East & Africa Competent cells Market By Type, From 2022 - 2027 ( USD Billion )
  2. Middle East & Africa Chemically Market By Region, From 2022 - 2027 ( USD Billion )
  3. Middle East & Africa Electro Competent Market By Region, From 2022 - 2027 ( USD Billion )
  4. Middle East & Africa Competent cells Market By Application, From 2022 - 2027 ( USD Billion )
  5. Middle East & Africa SubCloning Market By Region, From 2022 - 2027 ( USD Billion )
  6. Middle East & Africa Phage Display Library Production Market By Region, From 2022 - 2027 ( USD Billion )
  7. Middle East & Africa Unstable DNA Cloning Market By Region, From 2022 - 2027 ( USD Billion )
  8. Middle East & Africa High-Throughput Cloning Market By Region, From 2022 - 2027 ( USD Billion )
  9. Middle East & Africa  Mutagenesis Market By Region, From 2022 - 2027 ( USD Billion )
  10. Middle East & Africa Competent cells Market By End User, From 2022 - 2027 ( USD Billion )
  11. Middle East & Africa Pharmaceutical Companies Market By Region, From 2022 - 2027 ( USD Billion )
  12. Middle East & Africa Academia Market By Region, From 2022 - 2027 ( USD Billion )
  13. Middle East Competent cells Market By Type, From 2022 - 2027 ( USD Billion )
  14. Middle East Competent cells Market By Application, From 2022 - 2027 ( USD Billion )
  15. Middle East Competent cells Market By End User, From 2022 - 2027 ( USD Billion )
  16. Africa Competent cells Market By Type, From 2022 - 2027 ( USD Billion )
  17. Africa Competent cells Market By Application, From 2022 - 2027 ( USD Billion )
  18. Africa Competent cells Market By End User, From 2022 - 2027 ( USD Billion )

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

2875


pdf excel
$

3220


pdf excel powerbi
$

4600


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2875

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample